Loading company…
Speclipse, founded in 2015 in Gyeonggi-do, South Korea, develops laser-based and AI cancer diagnostic devices for dermatology.
Speclipse, Inc., founded in 2015 in Gyeonggi-do, South Korea, develops cancer diagnostic solutions using Laser-Induced Plasma Spectroscopy (LIPS) and artificial intelligence. Its portable Spectra-Scope device analyzes skin tissue to support rapid oncological diagnostics for dermatologists, and it also makes the Pico-K and Bellus-Q laser devices. The company was co-founded by Sung Pyun and Wanki Min, with Sung Pyun as CEO. Its Series B round raised KRW 9 billion on August 13, 2021, from BNH Investment, MiCo, Shinhan Capital and Signite.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in